Canine Atopic Dermatitis Global Market Report 2026
상품코드:1938640
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
개 아토피 피부염 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 27억 6,000만 달러에서 2026년에는 30억 5,000만 달러로, CAGR 10.5%로 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 반려견의 알레르기성 피부질환 유병률 증가, 반려동물 보호자 및 수의사의 인식 개선, 기존 표적치료제의 제한적 선택, 글루코코르티코이드 및 항히스타민제의 주요 치료법 채택, 수의피부과 서비스 확대 등을 꼽을 수 있습니다.
개 아토피 피부염 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 45억 달러에 달하며, CAGR은 10.2%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 신규 생물제제 및 모노클로널 항체(mAbs) 개발, 반려동물 정밀의료에 대한 투자 증가, 외용 및 전신 면역요법의 보급 확대, 온라인 및 소매 유통 채널의 성장, 건강기능식품을 포함한 예방 및 지지요법에 대한 집중을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 표적치료에 대한 모노클로널 항체(mAbs)의 사용 증가, 반려견의 알레르겐 특이적 면역요법(ASIT) 도입 확대, 약용 샴푸 및 외용제 수요 증가, 피부 장벽 기능 지원을 위한 건강기능식품 및 프로바이오틱스 확대, 반려견의 아토피 피부염에 대한 견종별 치료 접근에 대한 집중 등을 들 수 있습니다.
개 피부 알레르기 사례 증가는개 아토피 피부염 시장의 성장을 촉진할 것으로 예측됩니다. 개의 피부 알레르기는 꽃가루, 특정 음식, 벼룩 물림 등의 알레르겐에 대해 면역체계가 과민반응을 일으켜 가려움증, 발적, 염증 등의 증상을 유발하는 질환입니다. 이러한 증가의 원인 중 하나는 환경 오염 물질과 알레르겐에 대한 노출 증가로 면역 반응이 강화되어 피부의 불편함을 유발할 수 있기 때문입니다. 반려견 아토피 피부염 치료는 염증과 가려움증을 최소화하고 2차 감염을 예방하여 이러한 문제를 완화하고 반려견의 피부 건강과 편안함을 개선합니다. 예를 들어 2024년 1월 미국 국립보건원(NIH)이 발표한 조사에 따르면 7,915명의 반려견 주인(28.7%)이 반려견이 피부 관련 질환을 경험했다고 응답했습니다. 데이터에 따르면 피부 문제는 연령에 따라 꾸준히 증가하여 강아지의 경우 7%, 노령견의 경우 37%에 달할 전망입니다. 이러한 유병률 증가는 반려견 아토피 피부염 시장의 성장에 기여하고 있습니다.
반려동물 사육 수 증가도 반려견 아토피 피부염 시장 성장에 기여하고 있습니다. 반려동물 사육은 가정 환경에서 개, 고양이 등 반려동물을 기르고 돌보는 것을 말합니다. 이러한 추세의 주요 요인은 반려동물의 인간화가 진행되면서 동물을 가족의 일원으로, 정서적 지지와 동반자로 인식하는 경우가 증가하고 있기 때문입니다. 반려견의 아토피 피부염에 대한 대응은 만성적인 가려움증과 염증을 완화하고 피부 건강을 증진시키며 전반적인 편안함과 행복감을 높여 반려동물의 삶의 질을 향상시키는 데 중요한 역할을 합니다. 예를 들어 2025년 4월 미국 반려동물 제품 협회(APPA)가 발표한 자료에 따르면 반려동물을 키우는 미국 가구 수는 9,400만 가구(71%)로 2023-2024년 8,690만 가구(66%)에 비해 증가했습니다. 증가했습니다. 이러한 반려동물 양육 가구 증가는 반려견 아토피 피부염 치료제 시장 수요 증가를 견인하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Canine atopic dermatitis is a long-term, inflammatory skin disorder in dogs triggered by allergic reactions to environmental allergens like pollen, dust mites, mold, or certain foods. It is a hereditary condition that results in severe itching, skin redness, and frequent skin infections. The main goal of treating canine atopic dermatitis is to alleviate itching, decrease inflammation, and control secondary infections to enhance the dog's overall well-being.
The primary product categories used in the management of canine atopic dermatitis include glucocorticoids, antihistamines, immunosuppressants, monoclonal antibodies (mAbs), and other related therapies. Glucocorticoids are synthetic, broad-acting hormones that effectively relieve itching and inflammation by suppressing the immune response. This condition affects a variety of dog breeds, including German Shepherds, Terriers, Retrievers, and others, with common indications such as ectoparasites, food allergies, and allergic skin infections. Treatment methods include oral, topical, and injectable routes, and these products are distributed through veterinary clinics, retail pharmacies, online pharmacies, and other distribution channels.
Tariffs have impacted the canine atopic dermatitis market by increasing the cost of imported biologics, monoclonal antibodies, and specialty medications, which has affected veterinary clinics and pharmacies, particularly in North America and Europe. Segments like mAbs and immunosuppressants are most affected due to high import dependency. On the positive side, tariffs are driving local manufacturing initiatives, encouraging regional production of targeted therapies, and potentially improving supply chain resilience in the long term.
The canine atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides canine atopic dermatitis market statistics, including canine atopic dermatitis industry global market size, regional shares, competitors with a canine atopic dermatitis market share, detailed canine atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the canine atopic dermatitis industry. This canine atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The canine atopic dermatitis market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising prevalence of allergic skin conditions in dogs, growing awareness among pet owners and veterinarians, limited availability of targeted therapies in the past, adoption of glucocorticoids and antihistamines as primary treatments, expansion of veterinary dermatology services.
The canine atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of novel biologics and mAbs, increasing investments in precision medicine for pets, rising adoption of topical and systemic immunotherapies, growth in online and retail distribution channels, focus on preventive and supportive care including nutraceuticals. Major trends in the forecast period include increasing use of monoclonal antibodies (mabs) for targeted therapy, growing adoption of allergen-specific immunotherapy (asit) in dogs, rising demand for medicated shampoos and topical treatments, expansion of nutraceuticals and probiotics for skin barrier support, focus on breed-specific treatment approaches for canine atopic dermatitis.
The growing number of skin allergy cases in dogs is expected to drive the expansion of the canine atopic dermatitis market. Skin allergies in dogs occur when their immune system overreacts to allergens like pollen, certain foods, or flea bites, leading to symptoms such as itching, redness, and irritation. This increase is partly due to greater exposure to environmental pollutants and allergens, which can trigger intensified immune responses and cause skin discomfort. Treatments for canine atopic dermatitis help alleviate these issues by minimizing inflammation and itching, as well as preventing secondary infections, thereby improving dogs' skin health and comfort. For example, in January 2024, the National Institutes of Health (NIH), a US-based government agency, reported that 7,915 dog owners (28.7%) indicated their dogs had experienced skin-related conditions. The data showed a steady increase in skin issues with age, from 7% in puppies to 37% in senior dogs. This rising prevalence is contributing to the growth of the canine atopic dermatitis market.
The increase in pet ownership is also contributing to the growth of the canine atopic dermatitis market. Pet ownership involves caring for domesticated animals, such as dogs, cats, and other companions, within a household setting. A key driver of this trend is the growing humanization of pets, where animals are increasingly seen as family members and sources of emotional support and companionship. Addressing canine atopic dermatitis plays an essential role in improving pets' lives by easing chronic itching and inflammation, enhancing skin health, and boosting overall comfort and well-being. For instance, in April 2025, the American Pet Products Association (APPA), a US-based trade association, reported that 94 million US households (71%) owned a pet, up from 86.9 million households (66%) in 2023-2024. As a result, the increase in pet ownership is fueling demand in the canine atopic dermatitis market.
Leading companies in the canine atopic dermatitis market are pursuing regulatory approvals to expand the global reach and availability of their treatments. Regulatory approvals are formal authorizations granted by health authorities after verifying that medical products meet safety, efficacy, and quality standards through comprehensive testing. For example, in September 2024, Elanco Animal Health Inc., a US-based pharmaceutical company focused on animal health, received US FDA approval for Zenrelia, a once-daily oral JAK inhibitor designed to treat allergic and atopic dermatitis in dogs. Zenrelia represents a significant innovation by addressing chronic, acute, or seasonal itching and inflammation with a single daily tablet. It functions by targeting the source of the itch and blocking the signaling pathways responsible for allergic reactions, thereby breaking the itch-scratch cycle. The treatment provides noticeable improvement from the first dose and helps minimize rebound itching, which is a common drawback in dogs treated with competing JAK inhibitors.
Major companies operating in the canine atopic dermatitis market are Merck & Co. Inc., Zoetis Inc., Hill's Pet Nutrition Inc., Royal Canin SAS, Ceva Sante Animale S.A., Virbac S.A., Elanco Animal Health Inc., Dechra Pharmaceuticals PLC, Vetoquinol S.A., Bioiberica S.A.U., Bimeda Animal Health Limited, Animal Dermatology Group Inc., Kindred Biosciences Inc., Nextmune AB, OKAVA Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Toray Industries Inc., LEO Pharma A/S, PetIQ Inc., Hester Biosciences Limited, Ourofino Saude Animal, Swedencare AB, Orion Corporation, Norbrook Laboratories Ltd., AB Science SA.
North America was the largest region in the canine atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the canine atopic dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the canine atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The canine atopic dermatitis market consists of sales of products including medicated shampoos, hypoallergenic diets, omega-3 fatty acid supplements, skin barrier repair creams, and topical antimicrobial or antifungal treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Canine Atopic Dermatitis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses canine atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for canine atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine atopic dermatitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product: Glucocorticoids; Antihistamines; Immunosuppressants; Monoclonal Antibodies (mAbs); Other Products
2) By Dog Breed: German Shepherd; Terriers; Retrievers; Other Dog Breeds
3) By Indication: Ectoparasites; Food Allergy; Allergic Skin Infections; Other Indications
4) By Route Of Administration: Oral; Topical; Injectable
5) By Distribution Channel: Veterinary Clinics; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Glucocorticoids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Hydrocortisone; Triamcinolone
2) By Antihistamines: Diphenhydramine; Hydroxyzine; Cetirizine; Loratadine; Chlorpheniramine
3) By Immunosuppressants: Cyclosporine; Tacrolimus; Azathioprine; Mycophenolate Mofetil
4) By Monoclonal Antibodies: Lokivetmab; Investigational Monoclonal Antibodies
5) By Other Products: Essential Fatty Acid Supplements; Medicated Shampoos And Sprays; Allergen-Specific Immunotherapy (ASIT); Skin Barrier Repair Creams; Nutraceuticals And Probiotics
Companies Mentioned: Merck & Co. Inc.; Zoetis Inc.; Hill's Pet Nutrition Inc.; Royal Canin SAS; Ceva Sante Animale S.A.; Virbac S.A.; Elanco Animal Health Inc.; Dechra Pharmaceuticals PLC; Vetoquinol S.A.; Bioiberica S.A.U.; Bimeda Animal Health Limited; Animal Dermatology Group Inc.; Kindred Biosciences Inc.; Nextmune AB; OKAVA Pharmaceuticals Inc.; Boehringer Ingelheim International GmbH; Toray Industries Inc.; LEO Pharma A/S; PetIQ Inc.; Hester Biosciences Limited; Ourofino Saude Animal; Swedencare AB; Orion Corporation; Norbrook Laboratories Ltd.; AB Science SA.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Use Of Monoclonal Antibodies (Mabs) For Targeted Therapy
4.2.2 Growing Adoption Of Allergen-Specific Immunotherapy (Asit) In Dogs
4.2.3 Rising Demand For Medicated Shampoos And Topical Treatments
4.2.4 Expansion Of Nutraceuticals And Probiotics For Skin Barrier Support
4.2.5 Focus On Breed-Specific Treatment Approaches For Canine Atopic Dermatitis
5. Canine Atopic Dermatitis Market Analysis Of End Use Industries
5.1 Veterinary Clinics
5.2 Retail Pharmacies
5.3 Online Pharmacies
5.4 Veterinary Hospitals
5.5 Pet Owners
6. Canine Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Canine Atopic Dermatitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Canine Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Canine Atopic Dermatitis Market Size, Comparisons And Growth Rate Analysis
7.3. Global Canine Atopic Dermatitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Canine Atopic Dermatitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Canine Atopic Dermatitis Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Canine Atopic Dermatitis Market Segmentation
9.1. Global Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Glucocorticoids, Antihistamines, Immunosuppressants, Monoclonal Antibodies (mAbs), Other Products
9.2. Global Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
German Shepherd, Terriers, Retrievers, Other Dog Breeds
9.3. Global Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ectoparasites, Food Allergy, Allergic Skin Infections, Other Indications
9.4. Global Canine Atopic Dermatitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Topical, Injectable, Other
9.5. Global Canine Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
9.6. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lokivetmab, Investigational Monoclonal Antibodies
9.10. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics
10. Canine Atopic Dermatitis Market Regional And Country Analysis
10.1. Global Canine Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Canine Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Canine Atopic Dermatitis Market
12.1. China Canine Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Canine Atopic Dermatitis Market
13.1. India Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Canine Atopic Dermatitis Market
14.1. Japan Canine Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Canine Atopic Dermatitis Market
15.1. Australia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Canine Atopic Dermatitis Market
16.1. Indonesia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Canine Atopic Dermatitis Market
17.1. South Korea Canine Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Canine Atopic Dermatitis Market
19.1. South East Asia Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Canine Atopic Dermatitis Market
20.1. Western Europe Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Canine Atopic Dermatitis Market
21.1. UK Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Canine Atopic Dermatitis Market
22.1. Germany Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Canine Atopic Dermatitis Market
23.1. France Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Canine Atopic Dermatitis Market
24.1. Italy Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Canine Atopic Dermatitis Market
25.1. Spain Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Canine Atopic Dermatitis Market
26.1. Eastern Europe Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Canine Atopic Dermatitis Market
27.1. Russia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Canine Atopic Dermatitis Market
28.1. North America Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Canine Atopic Dermatitis Market
29.1. USA Canine Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Canine Atopic Dermatitis Market
31.1. South America Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Canine Atopic Dermatitis Market
32.1. Brazil Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Canine Atopic Dermatitis Market
33.1. Middle East Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Canine Atopic Dermatitis Market
34.1. Africa Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Canine Atopic Dermatitis Market Regulatory and Investment Landscape
36. Canine Atopic Dermatitis Market Competitive Landscape And Company Profiles
